The spectral exponent of the resting EEG indexes the presence of consciousness during unresponsiveness induced by propofol, xenon, and ketamine.


Journal

NeuroImage
ISSN: 1095-9572
Titre abrégé: Neuroimage
Pays: United States
ID NLM: 9215515

Informations de publication

Date de publication:
01 04 2019
Historique:
received: 24 09 2018
revised: 20 12 2018
accepted: 09 01 2019
pubmed: 15 1 2019
medline: 25 1 2020
entrez: 15 1 2019
Statut: ppublish

Résumé

Despite the absence of responsiveness during anesthesia, conscious experience may persist. However, reliable, easily acquirable and interpretable neurophysiological markers of the presence of consciousness in unresponsive states are still missing. A promising marker is based on the decay-rate of the power spectral density (PSD) of the resting EEG. We acquired resting electroencephalogram (EEG) in three groups of healthy participants (n = 5 each), before and during anesthesia induced by either xenon, propofol or ketamine. Dosage of each anesthetic agent was tailored to yield unresponsiveness (Ramsay score = 6). Delayed subjective reports assessed whether conscious experience was present ('Conscious report') or absent/inaccessible to recall ('No Report'). We estimated the decay of the PSD of the resting EEG-after removing oscillatory peaks-via the spectral exponent β, for a broad band (1-40 Hz) and narrower sub-bands (1-20 Hz, 20-40 Hz). Within-subject anesthetic changes in β were assessed. Furthermore, based on β, 'Conscious report' states were discriminated against 'no report' states. Finally, we evaluated the correlation of the resting spectral exponent with a recently proposed index of consciousness, the Perturbational Complexity Index (PCI), derived from a previous TMS-EEG study. The spectral exponent of the resting EEG discriminated states in which consciousness was present (wakefulness, ketamine) from states where consciousness was reduced or abolished (xenon, propofol). Loss of consciousness substantially decreased the (negative) broad-band spectral exponent in each subject undergoing xenon or propofol anesthesia-indexing an overall steeper PSD decay. Conversely, ketamine displayed an overall PSD decay similar to that of wakefulness-consistent with the preservation of consciousness-yet it showed a flattening of the decay in the high-frequencies (20-40 Hz)-consistent with its specific mechanism of action. The spectral exponent was highly correlated to PCI, corroborating its interpretation as a marker of the presence of consciousness. A steeper PSD of the resting EEG reliably indexed unconsciousness in anesthesia, beyond sheer unresponsiveness.

Identifiants

pubmed: 30639334
pii: S1053-8119(19)30024-2
doi: 10.1016/j.neuroimage.2019.01.024
pii:
doi:

Substances chimiques

Anesthetics, General 0
Xenon 3H3U766W84
Ketamine 690G0D6V8H
Propofol YI7VU623SF

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

631-644

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Michele Angelo Colombo (MA)

Neurosurgical Intensive Care, ASST Grande Ospedale Metropolitano Niguarda, Milan, 20162, Italy. Electronic address: milecombo@gmail.com.

Martino Napolitani (M)

Dipartimento di Scienze Biomediche e Cliniche "L. Sacco", Università Degli Studi di Milano, 20157 Milan, Italy; Department of Health Science, School of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy.

Melanie Boly (M)

Department of Neurology and Department of Psychiatry, University of Wisconsin, Madison, USA.

Olivia Gosseries (O)

Coma Science Group, GIGA-Consciousness, University and University Hospital of Liège, 4000 Liège, Belgium.

Silvia Casarotto (S)

Dipartimento di Scienze Biomediche e Cliniche "L. Sacco", Università Degli Studi di Milano, 20157 Milan, Italy.

Mario Rosanova (M)

Dipartimento di Scienze Biomediche e Cliniche "L. Sacco", Università Degli Studi di Milano, 20157 Milan, Italy; Fondazione Europea per La Ricerca Biomedica, Milan, Italy.

Jean-Francois Brichant (JF)

Department of Anaesthesia and Intensive Care Medicine, Liège University Hospital, 4000 Liège, Belgium.

Pierre Boveroux (P)

Department of Anaesthesia and Intensive Care Medicine, Liège University Hospital, 4000 Liège, Belgium.

Steffen Rex (S)

Department of Anaesthesiology and Department of Cardiovascular Sciences, University Hospitals of the KU Leuven, KU Leuven, 3000 Leuven, Belgium.

Steven Laureys (S)

Coma Science Group, GIGA-Consciousness, University and University Hospital of Liège, 4000 Liège, Belgium.

Marcello Massimini (M)

Dipartimento di Scienze Biomediche e Cliniche "L. Sacco", Università Degli Studi di Milano, 20157 Milan, Italy; Istituto Di Ricovero e Cura a Carattere Scientifico, Fondazione Don Carlo Gnocchi, 20148 Milan, Italy.

Arturo Chieregato (A)

Neurosurgical Intensive Care, ASST Grande Ospedale Metropolitano Niguarda, Milan, 20162, Italy.

Simone Sarasso (S)

Dipartimento di Scienze Biomediche e Cliniche "L. Sacco", Università Degli Studi di Milano, 20157 Milan, Italy. Electronic address: simone.sarasso@unimi.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH